by administrator | Apr 18, 2018 | News, Novo Nordisk
See original story here Once-daily Xultophy® has been shown to help patients achieve blood glucose targets Novo Nordisk announced today that Health Canada has approved Xultophy®as an adjunct to lifestyle modifications, for the once-daily treatment of adults with type...
by administrator | Apr 12, 2018 | Adaptiiv, News
See original story here CORALVILLE, Iowa, April 12, 2018 /PRNewswire/ — CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, and Adaptiiv (formerly 3D Bolus), the definitive 3D technology platform...
